Who invested in iQure Pharma?
iQure Pharma's investors include National Institutes of Health and Keiretsu Forum.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$4.3Mraised across 3 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $2.8M sold, first sale Sept 2026
Source recordedSEC filing: $650K sold
Source recordedSEC filing: $1.5M sold, first sale Sept 2025
From iQure Pharma's own website: 2 founders, 5 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
iQure Pharma's investors include National Institutes of Health and Keiretsu Forum.
iQure Pharma has raised $4.3M across 3 rounds since 2025. One round did not disclose an amount, so the total is a floor.
iQure Pharma's most recent round, $2.8M, was in Sept 2026.
Its most recent round, $2.8M in Sept 2026, is also its largest on record.
iQure Pharma's first round on record, in Nov 2025, was backed by National Institutes of Health and Keiretsu Forum.
iQure Pharma's latest named round is a Venture, in Jun 2026.
iQure Pharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.